Name	Gene(s)	Protein change	Condition(s)	Clinical significance (Last reviewed)	Review status	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	
NM_007294.4(BRCA1):c.5579A>C (p.His1860Pro)	BRCA1	H1860P, H1881P, H756P, H1813P, H1748P, H1771P, H1789P, H1812P, H1818P, H1857P, H1859P, H643P, H644P, H669P, H675P, H685P, H686P, H689P, H710P, H714P, H715P, H730P, H731P, H755P, H779P, H991P, H1706P, H1731P, H1732P, H1772P, H1790P, H1793P, H1811P, H1833P, H1840P, H1882P, H448P, H580P, H668P, H690P, H753P, H757P, H778P, H1563P, H1733P, H1749P, H1770P, H1788P, H1832P, H1841P, H1855P, H1858P, H1880P, H629P, H647P, H648P, H687P, H712P, H716P, H717P, H718P, H754P, H1564P, H1691P, H1747P, H1776P, H1791P, H1792P, H1816P, H1817P, H1819P, H1834P, H1856P, H589P, H630P, H667P, H677P, H708P, H709P, H732P, H992P	not provided	Benign(Last reviewed: Jul 13, 2012)	no assertion criteria provided	VCV000041833	17	41197708	17	43045691	41833	50272	rs201196020	NC_000017.11:43045690:T:G
NM_007294.4(BRCA1):c.5576C>G (p.Pro1859Arg)	BRCA1	P1859R, P1812R, P755R, P1880R, P1879R, P447R, P579R, P629R, P666R, P676R, P707R, P708R, P713R, P714R, P730R, P756R, P777R, P1732R, P1747R, P1787R, P1788R, P1810R, P1816R, P1839R, P1854R, P588R, P646R, P647R, P667R, P685R, P688R, P709R, P711R, P754R, P991R, P1690R, P1769R, P1770R, P1771R, P1775R, P1789R, P1790R, P1791R, P1818R, P1858R, P642R, P684R, P716R, P717R, P729R, P731R, P753R, P990R, P1562R, P1730R, P1731R, P1748R, P1792R, P1815R, P1817R, P1831R, P1840R, P1855R, P1856R, P1881R, P628R, P643R, P668R, P674R, P686R, P689R, P715R, P752R, P778R, P1563R, P1705R, P1746R, P1811R, P1832R, P1833R, P1857R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055634	17	41197711	17	43045694	55634	70301	rs80357322	NC_000017.11:43045693:G:C
NM_007294.4(BRCA1):c.5572A>C (p.Ile1858Leu)	BRCA1	I1858L, I1879L, I1811L, I754L, I1561L, I1562L, I1730L, I1745L, I1786L, I1789L, I1830L, I1831L, I1856L, I1857L, I1880L, I578L, I666L, I675L, I685L, I688L, I713L, I716L, I729L, I753L, I777L, I989L, I1689L, I1731L, I1747L, I1774L, I1788L, I1809L, I1810L, I1814L, I1832L, I1838L, I1839L, I446L, I628L, I645L, I667L, I673L, I687L, I706L, I707L, I708L, I715L, I751L, I752L, I776L, I642L, I683L, I710L, I714L, I728L, I755L, I1704L, I1787L, I1815L, I1817L, I1853L, I1854L, I1878L, I1729L, I1746L, I1768L, I1769L, I1770L, I1790L, I1791L, I1816L, I1855L, I587L, I627L, I641L, I646L, I665L, I684L, I712L, I730L, I990L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000183951	17	41197715	17	43045698	183951	184864	rs765656957	NC_000017.11:43045697:T:G
NM_007294.4(BRCA1):c.5531T>G (p.Leu1844Arg)	BRCA1	L1844R, L740R, L1865R, L1797R, L1732R, L1775R, L1776R, L1796R, L1801R, L1825R, L1841R, L1864R, L573R, L627R, L628R, L631R, L653R, L659R, L739R, L1675R, L1690R, L1754R, L1756R, L1760R, L1800R, L1803R, L1817R, L1842R, L1866R, L564R, L613R, L632R, L651R, L692R, L698R, L699R, L702R, L716R, L975R, L976R, L1548R, L1717R, L1731R, L1755R, L1772R, L1773R, L1802R, L1818R, L1824R, L1840R, L614R, L652R, L671R, L674R, L696R, L701R, L738R, L741R, L1547R, L1715R, L1716R, L1733R, L1774R, L1777R, L1795R, L1816R, L1839R, L1843R, L432R, L661R, L669R, L670R, L673R, L693R, L694R, L700R, L714R, L715R, L737R, L762R, L763R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055615	17	41197756	17	43045739	55615	70282	rs80357323	NC_000017.11:43045738:A:C
NM_007294.4(BRCA1):c.5456A>G (p.Asn1819Ser)	BRCA1	N1819S, N1840S, N715S, N1772S, N1665S, N1692S, N1731S, N1748S, N1751S, N1776S, N1777S, N1792S, N1814S, N1839S, N407S, N539S, N589S, N626S, N628S, N636S, N644S, N667S, N668S, N675S, N676S, N712S, N713S, N716S, N738S, N950S, N951S, N1523S, N1691S, N1708S, N1729S, N1735S, N1749S, N1750S, N1800S, N1815S, N1817S, N602S, N606S, N673S, N674S, N677S, N690S, N1522S, N1690S, N1706S, N1730S, N1771S, N1778S, N1793S, N1816S, N548S, N588S, N603S, N607S, N645S, N648S, N649S, N737S, N1650S, N1707S, N1747S, N1752S, N1770S, N1775S, N1791S, N1799S, N1818S, N1841S, N627S, N634S, N646S, N669S, N671S, N689S, N691S, N714S	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 13, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055585	17	41199671	17	43047654	55585	70252	rs80357286	NC_000017.11:43047653:T:C
NM_007294.4(BRCA1):c.5411T>A (p.Val1804Asp)	BRCA1	V1804D, C675*, V1757D, V1825D, V700D, C1779*, V1676D, V1716D, V1720D, V1732D, V1735D, V1756D, V1761D, V1777D, V1785D, V1801D, V1824D, V574D, V613D, V630D, V631D, V675D, V699D, V935D, C1778*, V1507D, V1635D, V1675D, V1733D, V1734D, V1736D, V1737D, V1763D, V1800D, V1826D, V392D, V573D, V587D, V588D, V611D, V653D, V658D, V659D, V662D, V698D, V723D, C1731*, C674*, V1691D, V1692D, V1715D, V1760D, V1762D, V1776D, V1778D, V1784D, V524D, V591D, V612D, V619D, V621D, V629D, V634D, V656D, V661D, V674D, V936D, C1732*, C1736*, C1737*, C1738*, C1777*, V1508D, V1650D, V1677D, V1693D, V1714D, V1755D, V1799D, V1802D, V1803D, V533D, V592D, V633D, V652D, V654D, V660D, V676D, V697D, V701D, V722D	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055568	17	41199716	17	43047699	55568	70235	rs80356920	NC_000017.11:43047698:A:T
NM_007294.4(BRCA1):c.5409T>C (p.Gly1803=)	BRCA1	C675R, C1731R, C1737R, C1738R, C674R, C1778R, C1779R, C1777R, C1732R, C1736R	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Jan 19, 2021)	criteria provided, multiple submitters, no conflicts	VCV000868463	17	41199718	17	43047701	868463	853393	rs2050995166	NC_000017.11:43047700:A:G
NM_007294.4(BRCA1):c.5402G>A (p.Gly1801Asp)	BRCA1	G1801D, G1754D, G1822D, G697D, G1504D, G1647D, G1799D, G521D, G588D, G589D, G609D, G627D, G631D, G657D, G659D, G694D, G720D, G933D, G571D, G584D, G585D, G608D, G610D, G656D, G658D, G671D, G696D, G698D, G1673D, G1689D, G1711D, G1712D, G1731D, G1781D, G1796D, G1734D, G1760D, G1773D, G1774D, G1797D, G1823D, G1505D, G1674D, G1688D, G1690D, G1730D, G1733D, G1752D, G1775D, G1800D, G389D, G570D, G618D, G626D, G649D, G655D, G672D, G695D, G1632D, G1672D, G1713D, G1729D, G1732D, G1753D, G1757D, G1758D, G1759D, G1782D, G1798D, G1821D, G530D, G616D, G628D, G630D, G650D, G651D, G653D, G673D, G719D, G932D	not provided|not specified|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Oct 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000142834	17	41201142	17	43049125	142834	152548	rs531210457	NC_000017.11:43049124:C:T
NM_007294.4(BRCA1):c.5347A>T (p.Met1783Leu)	BRCA1	M679L, M1736L, M1783L, M1804L, M1486L, M1654L, M1670L, M1671L, M1712L, M1715L, M1741L, M1757L, M1763L, M503L, M512L, M552L, M567L, M609L, M637L, M640L, M677L, M1629L, M1672L, M1693L, M1713L, M1714L, M1734L, M1739L, M1778L, M1781L, M1782L, M1803L, M600L, M612L, M613L, M632L, M638L, M653L, M655L, M676L, M915L, M1614L, M1656L, M1695L, M1711L, M1740L, M1779L, M1805L, M553L, M571L, M590L, M591L, M592L, M608L, M633L, M635L, M639L, M680L, M702L, M1487L, M1655L, M1694L, M1716L, M1735L, M1742L, M1755L, M1756L, M1764L, M1780L, M371L, M566L, M570L, M598L, M610L, M631L, M641L, M654L, M678L, M701L, M914L	Hereditary breast ovarian cancer syndrome	Benign(Last reviewed: Jul 20, 2021)	criteria provided, single submitter	VCV000865370	17	41201197	17	43049180	865370	853523	rs80357012	NC_000017.11:43049179:T:A
NM_007294.4(BRCA1):c.5252G>A (p.Arg1751Gln)	BRCA1	R1751Q, R1704Q, R1772Q, R647Q, R1455Q, R1639Q, R1662Q, R1680Q, R1681Q, R1710Q, R1747Q, R1771Q, R1773Q, R539Q, R559Q, R580Q, R600Q, R601Q, R623Q, R646Q, R669Q, R1582Q, R1623Q, R1624Q, R1661Q, R1679Q, R1684Q, R1708Q, R1709Q, R1732Q, R1746Q, R1750Q, R339Q, R471Q, R560Q, R576Q, R599Q, R603Q, R609Q, R644Q, R882Q, R1454Q, R1597Q, R1682Q, R1703Q, R1723Q, R1748Q, R480Q, R534Q, R577Q, R578Q, R581Q, R605Q, R606Q, R621Q, R648Q, R883Q, R1622Q, R1638Q, R1640Q, R1663Q, R1683Q, R1702Q, R1707Q, R1724Q, R1725Q, R1731Q, R1749Q, R520Q, R521Q, R535Q, R538Q, R558Q, R566Q, R568Q, R607Q, R608Q, R622Q, R645Q, R670Q	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055481	17	41209094	17	43057077	55481	70148	rs80357442	NC_000017.11:43057076:C:T
NM_007294.4(BRCA1):c.5198A>G (p.Asp1733Gly)	BRCA1	D1733G, D1754G, D629G, D1686G, D1564G, D1604G, D1645G, D1661G, D1665G, D1684G, D1692G, D1705G, D1706G, D1728G, D502G, D517G, D550G, D581G, D603G, D605G, D626G, D1436G, D1605G, D1606G, D1644G, D1662G, D1664G, D1691G, D1714G, D1730G, D1732G, D503G, D542G, D548G, D562G, D585G, D587G, D627G, D1437G, D1579G, D1620G, D1643G, D1663G, D1685G, D1690G, D1713G, D1729G, D1731G, D453G, D462G, D520G, D559G, D560G, D563G, D582G, D589G, D630G, D652G, D865G, D1621G, D1622G, D1666G, D1689G, D1707G, D1753G, D1755G, D321G, D516G, D521G, D540G, D541G, D558G, D583G, D588G, D590G, D591G, D604G, D628G, D651G, D864G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055453	17	41209148	17	43057131	55453	70120	rs80357270	NC_000017.11:43057130:T:C
NM_007294.4(BRCA1):c.5158A>G (p.Thr1720Ala)	BRCA1	T1720A, T616A, T1673A, T1741A, T1423A, T1630A, T1648A, T1649A, T1650A, T1652A, T1653A, T1672A, T1679A, T1716A, T1718A, T1742A, T308A, T440A, T503A, T504A, T508A, T546A, T549A, T617A, T1424A, T1566A, T1591A, T1592A, T1608A, T1700A, T1717A, T489A, T490A, T529A, T572A, T576A, T590A, T1609A, T1631A, T1651A, T1676A, T1677A, T1678A, T1692A, T1701A, T1715A, T527A, T537A, T547A, T550A, T568A, T575A, T591A, T592A, T615A, T638A, T639A, T851A, T852A, T1551A, T1593A, T1607A, T1632A, T1671A, T1693A, T1694A, T1719A, T1740A, T449A, T507A, T528A, T535A, T545A, T569A, T570A, T574A, T577A, T578A, T613A, T614A	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055438	17	41215385	17	43063368	55438	70105	rs56195342	NC_000017.11:43063367:T:C
NM_007294.4(BRCA1):c.5117G>C (p.Gly1706Ala)	BRCA1	G1706A, G1659A, G602A, G1727A, G1409A, G1595A, G1665A, G1703A, G426A, G435A, G489A, G493A, G494A, G521A, G523A, G555A, G556A, G558A, G560A, G576A, G578A, G599A, G838A, G1552A, G1577A, G1616A, G1617A, G1634A, G1636A, G1637A, G1658A, G1679A, G1680A, G1686A, G1704A, G294A, G514A, G564A, G600A, G624A, G1594A, G1639A, G1657A, G1663A, G1678A, G1702A, G1705A, G513A, G535A, G561A, G562A, G563A, G601A, G603A, G625A, G837A, G1410A, G1537A, G1578A, G1579A, G1593A, G1618A, G1635A, G1662A, G1664A, G1687A, G1701A, G1726A, G1728A, G475A, G476A, G490A, G515A, G531A, G532A, G533A, G536A, G554A, G577A	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055406	17	41215926	17	43063909	55406	70073	rs80356860	NC_000017.11:43063908:C:G
NM_007294.4(BRCA1):c.5044G>A (p.Glu1682Lys)	BRCA1	E1682K, E1635K, E1703K, E578K, E1513K, E1569K, E1594K, E1610K, E1613K, E1656K, E1662K, E1663K, E1678K, E1679K, E1702K, E402K, E1385K, E1553K, E1592K, E1634K, E1638K, E1639K, E1640K, E1654K, E1704K, E452K, E489K, E490K, E491K, E497K, E512K, E530K, E537K, E540K, E553K, E813K, E1386K, E1555K, E1571K, E1633K, E1655K, E1677K, E1680K, E1681K, E451K, E507K, E531K, E532K, E575K, E576K, E411K, E466K, E499K, E508K, E538K, E552K, E554K, E579K, E600K, E1528K, E1554K, E1570K, E1593K, E1611K, E1612K, E1615K, E1641K, E465K, E469K, E470K, E509K, E511K, E534K, E536K, E539K, E577K, E601K, E814K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055361	17	41219655	17	43067638	55361	70028	rs80356958	NC_000017.11:43067637:C:T
NM_007294.4(BRCA1):c.5024C>T (p.Thr1675Ile)	BRCA1	T1675I, T1696I, T1628I, T571I, T1506I, T1521I, T1562I, T1586I, T1606I, T1627I, T1631I, T1647I, T1648I, T1697I, T444I, T445I, T459I, T462I, T463I, T530I, T547I, T807I, T1563I, T1587I, T1603I, T1632I, T1649I, T1656I, T1674I, T1695I, T395I, T482I, T483I, T484I, T492I, T501I, T523I, T525I, T531I, T533I, T546I, T568I, T594I, T1378I, T1379I, T1546I, T1548I, T1585I, T1604I, T1605I, T1608I, T1626I, T1633I, T1634I, T1670I, T1671I, T1672I, T1673I, T490I, T502I, T545I, T569I, T572I, T593I, T1547I, T1564I, T1655I, T404I, T458I, T500I, T504I, T505I, T524I, T527I, T529I, T532I, T570I, T806I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000240811	17	41219675	17	43067658	240811	242767	rs150729791	NC_000017.11:43067657:G:A
NM_007294.4(BRCA1):c.4991T>C (p.Leu1664Pro)	BRCA1	L1664P, L1685P, L1617P, L560P, L1368P, L1510P, L1615P, L1622P, L1659P, L1684P, L1686P, L384P, L447P, L452P, L472P, L491P, L493P, L512P, L513P, L559P, L561P, L582P, L583P, L1495P, L1537P, L1593P, L1620P, L1637P, L1638P, L1661P, L1662P, L393P, L434P, L479P, L481P, L494P, L520P, L534P, L535P, L536P, L796P, L1535P, L1574P, L1576P, L1592P, L1594P, L1597P, L1623P, L1663P, L473P, L490P, L516P, L519P, L522P, L557P, L558P, L795P, L1367P, L1536P, L1551P, L1552P, L1553P, L1575P, L1595P, L1616P, L1621P, L1636P, L1644P, L1645P, L1660P, L433P, L448P, L451P, L471P, L489P, L514P, L518P, L521P	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037621	17	41219708	17	43067691	37621	46177	rs80357314	NC_000017.11:43067690:A:G
NM_007294.4(BRCA1):c.4985T>C (p.Phe1662Ser)	BRCA1	F1662S, F558S, F1615S, F1683S, F1621S, F1636S, F1657S, F1659S, F1661S, F469S, F470S, F477S, F512S, F519S, F520S, F532S, F555S, F1366S, F1549S, F1574S, F1592S, F1618S, F1508S, F1550S, F1572S, F1573S, F1591S, F1595S, F1619S, F1643S, F391S, F445S, F446S, F489S, F514S, F516S, F517S, F534S, F581S, F793S, F1365S, F1493S, F1590S, F1593S, F1613S, F1614S, F1642S, F1660S, F1682S, F382S, F431S, F449S, F471S, F479S, F487S, F488S, F492S, F510S, F518S, F533S, F557S, F1533S, F1534S, F1535S, F1551S, F1620S, F1634S, F1635S, F1658S, F1684S, F432S, F450S, F491S, F511S, F556S, F559S, F580S, F794S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055339	17	41222946	17	43070929	55339	70006	rs28897695	NC_000017.11:43070928:A:G
NM_007294.4(BRCA1):c.4956G>A (p.Met1652Ile)	BRCA1	M1652I, M548I, M1673I, M1605I, M1523I, M1582I, M1604I, M1611I, M1633I, M1649I, M459I, M460I, M467I, M477I, M502I, M504I, M510I, M546I, M1356I, M1563I, M1564I, M1580I, M1585I, M1483I, M1524I, M1525I, M1608I, M1632I, M1647I, M1672I, M372I, M421I, M461I, M482I, M500I, M507I, M524I, M545I, M549I, M1355I, M1498I, M1539I, M1540I, M1581I, M1583I, M1603I, M1624I, M1648I, M1650I, M1651I, M1674I, M439I, M440I, M481I, M501I, M506I, M522I, M547I, M570I, M783I, M1541I, M1562I, M1609I, M1610I, M1626I, M381I, M422I, M435I, M436I, M469I, M478I, M479I, M508I, M509I, M523I, M571I, M784I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041830	17	41222975	17	43070958	41830	50269	rs1799967	NC_000017.11:43070957:C:T
NM_007294.4(BRCA1):c.4955T>C (p.Met1652Thr)	BRCA1	M1652T, M1673T, M1605T, M548T, M1539T, M1583T, M1585T, M1603T, M1625T, M1626T, M1647T, M1650T, M1651T, M381T, M421T, M459T, M461T, M469T, M478T, M504T, M506T, M508T, M545T, M549T, M571T, M1356T, M1563T, M1611T, M1624T, M1632T, M1633T, M1649T, M439T, M440T, M467T, M501T, M510T, M522T, M523T, M1483T, M1498T, M1524T, M1525T, M1541T, M1562T, M1564T, M1580T, M1582T, M1608T, M1609T, M1674T, M422T, M435T, M436T, M460T, M477T, M481T, M500T, M502T, M509T, M783T, M1355T, M1523T, M1540T, M1581T, M1604T, M1610T, M1648T, M1672T, M372T, M479T, M482T, M507T, M524T, M546T, M547T, M570T, M784T	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037615	17	41222976	17	43070959	37615	46171	rs80356968	NC_000017.11:43070958:A:G
NM_007294.4(BRCA1):c.4913A>T (p.Glu1638Val)	BRCA1	E1591V, E1638V, E1659V, E534V, E1526V, E1527V, E1549V, E1589V, E1595V, E1637V, E1658V, E1660V, E358V, E425V, E467V, E487V, E488V, E494V, E496V, E535V, E1341V, E1469V, E1484V, E1548V, E1550V, E1566V, E1569V, E1571V, E1634V, E407V, E447V, E463V, E492V, E508V, E532V, E557V, E1342V, E1509V, E1510V, E1511V, E1525V, E1567V, E1610V, E1611V, E1612V, E1619V, E1635V, E367V, E426V, E455V, E464V, E468V, E486V, E493V, E510V, E556V, E769V, E1568V, E1590V, E1594V, E1596V, E1597V, E1618V, E1633V, E1636V, E408V, E421V, E422V, E445V, E446V, E453V, E465V, E490V, E495V, E509V, E531V, E533V, E770V	not specified	Benign(Last reviewed: Aug 15, 2023)	criteria provided, single submitter	VCV000868843	17	41223018	17	43071001	868843	854370	rs2052380495	NC_000017.11:43071000:T:A
NM_007294.4(BRCA1):c.4910C>T (p.Pro1637Leu)	BRCA1	P1637L, P1590L, P533L, P1658L, P1526L, P1547L, P1570L, P1595L, P1596L, P1632L, P1659L, P421L, P452L, P486L, P489L, P493L, P494L, P508L, P556L, P1341L, P1510L, P1524L, P1549L, P1566L, P1568L, P1609L, P1617L, P1636L, P366L, P406L, P425L, P463L, P464L, P466L, P485L, P495L, P507L, P1468L, P1525L, P1548L, P1567L, P1588L, P1593L, P1610L, P1634L, P1635L, P357L, P446L, P487L, P492L, P531L, P1340L, P1483L, P1508L, P1509L, P1565L, P1589L, P1594L, P1611L, P1618L, P1633L, P1657L, P407L, P420L, P424L, P444L, P445L, P454L, P462L, P467L, P491L, P532L, P534L, P509L, P530L, P555L, P768L, P769L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055314	17	41223021	17	43071004	55314	69981	rs80357048	NC_000017.11:43071003:G:A
NM_007294.4(BRCA1):c.4883T>C (p.Met1628Thr)	BRCA1	M1628T, M1649T, M524T, M1581T, M485T, M498T, M1501T, M1539T, M1558T, M1584T, M1600T, M1601T, M1602T, M1623T, M1648T, M397T, M411T, M435T, M458T, M476T, M477T, M1332T, M1517T, M1538T, M1540T, M1557T, M1561T, M1608T, M1609T, M348T, M357T, M412T, M416T, M437T, M453T, M454T, M455T, M478T, M482T, M499T, M523T, M525T, M760T, M1459T, M1474T, M1515T, M1579T, M1585T, M1586T, M1625T, M415T, M436T, M443T, M445T, M483T, M484T, M486T, M500T, M521T, M547T, M1331T, M1499T, M1500T, M1516T, M1556T, M1559T, M1580T, M1587T, M1624T, M1626T, M1627T, M1650T, M398T, M457T, M480T, M522T, M546T, M759T	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041828	17	41223048	17	43071031	41828	50267	rs4986854	NC_000017.11:43071030:A:G
NM_007294.4(BRCA1):c.4840C>T (p.Pro1614Ser)	BRCA1	P1614S, P1635S, P1567S, P510S, P1318S, P1460S, P1524S, P1526S, P1543S, P1544S, P1573S, P1609S, P1612S, P1613S, P1636S, P401S, P421S, P423S, P470S, P472S, P508S, P1501S, P1525S, P1542S, P1547S, P1565S, P1571S, P1572S, P1587S, P1588S, P1595S, P1610S, P343S, P429S, P471S, P484S, P486S, P509S, P511S, P746S, P1485S, P1486S, P1503S, P1586S, P1594S, P1634S, P383S, P384S, P397S, P422S, P431S, P439S, P441S, P443S, P464S, P469S, P485S, P507S, P532S, P533S, P745S, P1317S, P1445S, P1487S, P1502S, P1545S, P1566S, P1570S, P1611S, P334S, P398S, P402S, P440S, P444S, P462S, P463S, P466S, P468S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055301	17	41223091	17	43071074	55301	69968	rs70953660	NC_000017.11:43071073:G:A
NM_007294.4(BRCA1):c.4837A>G (p.Ser1613Gly)	BRCA1	S1613G, S1634G, S509G, S1566G, S1486G, S1524G, S1542G, S1543G, S1544G, S1633G, S382G, S383G, S397G, S421G, S428G, S442G, S461G, S468G, S744G, S1317G, S1541G, S1565G, S1572G, S1585G, S1593G, S1610G, S1612G, S422G, S430G, S439G, S462G, S463G, S469G, S471G, S483G, S507G, S532G, S1459G, S1500G, S1501G, S1502G, S1525G, S1546G, S1569G, S1571G, S1586G, S1587G, S1609G, S1635G, S333G, S342G, S400G, S438G, S465G, S484G, S485G, S506G, S510G, S1316G, S1444G, S1484G, S1485G, S1523G, S1564G, S1570G, S1594G, S1608G, S1611G, S396G, S401G, S420G, S440G, S443G, S467G, S470G, S508G, S531G, S745G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041827	17	41223094	17	43071077	41827	50266	rs1799966	NC_000017.11:43071076:T:C
NM_007294.4(BRCA1):c.4837A>T (p.Ser1613Cys)	BRCA1	S1613C, S1634C, S509C, S1566C, S1486C, S1502C, S1524C, S1541C, S1544C, S1569C, S1570C, S1608C, S1611C, S1633C, S1635C, S401C, S443C, S471C, S483C, S484C, S1459C, S1484C, S1485C, S1543C, S1572C, S1586C, S342C, S382C, S396C, S420C, S421C, S422C, S430C, S438C, S440C, S463C, S467C, S745C, S1316C, S1501C, S1525C, S1565C, S1571C, S1594C, S1612C, S333C, S397C, S400C, S428C, S439C, S465C, S468C, S485C, S508C, S510C, S531C, S532C, S744C, S1317C, S1444C, S1500C, S1523C, S1542C, S1546C, S1564C, S1585C, S1587C, S1593C, S1609C, S1610C, S383C, S442C, S461C, S462C, S469C, S470C, S506C, S507C	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Feb 27, 2023)	criteria provided, multiple submitters, no conflicts	VCV000037613	17	41223094	17	43071077	37613	46169	rs1799966	NC_000017.11:43071076:T:A
NM_007294.4(BRCA1):c.4816A>G (p.Lys1606Glu)	BRCA1	K1606E, K502E, K1627E, K1559E, K1452E, K1493E, K1495E, K1516E, K1534E, K1557E, K1563E, K1586E, K1601E, K1602E, K1603E, K1605E, K390E, K421E, K436E, K454E, K477E, K524E, K525E, K737E, K1310E, K1437E, K1477E, K1478E, K1518E, K1539E, K1579E, K1587E, K1628E, K376E, K389E, K393E, K460E, K463E, K464E, K499E, K500E, K1309E, K1479E, K1494E, K1535E, K1536E, K1537E, K1564E, K1578E, K326E, K375E, K413E, K415E, K431E, K433E, K455E, K456E, K462E, K478E, K738E, K1517E, K1558E, K1562E, K1565E, K1580E, K1604E, K1626E, K335E, K394E, K414E, K423E, K432E, K435E, K458E, K461E, K476E, K501E, K503E	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037612	17	41223115	17	43071098	37612	46168	rs80356943	NC_000017.11:43071097:T:C
NM_007294.4(BRCA1):c.4729T>C (p.Ser1577Pro)	BRCA1	S1577P, S473P, S1530P, S1598P, S1408P, S1466P, S1505P, S1529P, S1535P, S1549P, S1557P, S1558P, S1575P, S1576P, S347P, S360P, S365P, S406P, S407P, S425P, S447P, S1280P, S1487P, S1528P, S1534P, S1574P, S1597P, S361P, S392P, S403P, S426P, S429P, S435P, S449P, S495P, S1423P, S1450P, S1465P, S1488P, S1508P, S1510P, S1533P, S1536P, S1550P, S1572P, S1573P, S346P, S394P, S402P, S427P, S431P, S432P, S434P, S448P, S471P, S472P, S496P, S1281P, S1448P, S1449P, S1464P, S1489P, S1506P, S1507P, S1551P, S1599P, S297P, S306P, S364P, S384P, S385P, S386P, S404P, S433P, S470P, S474P, S708P, S709P	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Aug 15, 2023)	criteria provided, multiple submitters, no conflicts	VCV000055272	17	41223202	17	43071185	55272	69939	rs80356909	NC_000017.11:43071184:A:G
NM_007294.4(BRCA1):c.4691T>C (p.Leu1564Pro)	BRCA1	L1564P, L1585P, L1517P, L460P, L1435P, L1453P, L1492P, L1493P, L1494P, L1497P, L1516P, L1521P, L1560P, L1562P, L1586P, L347P, L351P, L391P, L393P, L412P, L482P, L1410P, L1436P, L1437P, L1452P, L1474P, L1476P, L1515P, L1520P, L1538P, L1544P, L1545P, L1561P, L1584P, L333P, L348P, L373P, L381P, L394P, L420P, L422P, L436P, L461P, L695P, L1267P, L1268P, L1495P, L1536P, L1537P, L284P, L352P, L371P, L379P, L390P, L416P, L418P, L421P, L457P, L458P, L483P, L696P, L1395P, L1451P, L1475P, L1522P, L1523P, L1559P, L1563P, L293P, L334P, L372P, L389P, L413P, L414P, L419P, L434P, L435P, L459P	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055262	17	41223240	17	43071223	55262	69929	rs56119278	NC_000017.11:43071222:A:G
NM_007294.4(BRCA1):c.4682C>T (p.Thr1561Ile)	BRCA1	T1561I, T1582I, T457I, T1514I, T411I, T419I, T433I, T455I, T1265I, T1392I, T1407I, T1448I, T1449I, T1450I, T1471I, T1473I, T1494I, T1517I, T1533I, T331I, T368I, T387I, T391I, T413I, T416I, T417I, T432I, T480I, T692I, T1433I, T1489I, T1490I, T1513I, T1520I, T1535I, T1542I, T1558I, T344I, T370I, T376I, T388I, T1434I, T1472I, T1491I, T1492I, T1512I, T1534I, T1541I, T1556I, T1559I, T290I, T345I, T349I, T378I, T386I, T409I, T410I, T415I, T1264I, T1432I, T1518I, T1519I, T1557I, T1560I, T1581I, T1583I, T281I, T330I, T348I, T369I, T390I, T418I, T431I, T454I, T456I, T458I, T479I, T693I	not provided|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|not specified|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Oct 23, 2022)	criteria provided, multiple submitters, no conflicts	VCV000055259	17	41223249	17	43071232	55259	69926	rs56158747	NC_000017.11:43071231:G:A
NM_007294.4(BRCA1):c.4636G>T (p.Asp1546Tyr)	BRCA1	D1546Y, D1567Y, D442Y, D1499Y, D1249Y, D1377Y, D1435Y, D1458Y, D1503Y, D1520Y, D1541Y, D1543Y, D1545Y, D1568Y, D333Y, D355Y, D376Y, D401Y, D418Y, D441Y, D465Y, D678Y, D1418Y, D1474Y, D1476Y, D1479Y, D1519Y, D1527Y, D1566Y, D275Y, D316Y, D330Y, D353Y, D354Y, D371Y, D372Y, D395Y, D396Y, D402Y, D404Y, D440Y, D1250Y, D1417Y, D1434Y, D1475Y, D1477Y, D1498Y, D1502Y, D1504Y, D1518Y, D1526Y, D1542Y, D1544Y, D361Y, D363Y, D373Y, D375Y, D394Y, D403Y, D417Y, D443Y, D1419Y, D1433Y, D1456Y, D1457Y, D1497Y, D1505Y, D315Y, D329Y, D334Y, D398Y, D400Y, D416Y, D439Y, D464Y, D677Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055246	17	41226387	17	43074370	55246	69913	rs28897691	NC_000017.11:43074369:C:A
NM_007294.4(BRCA1):c.4636G>A (p.Asp1546Asn)	BRCA1	D1546N, D1567N, D442N, D1499N, D1250N, D1417N, D1433N, D1498N, D1520N, D1542N, D1545N, D1566N, D1568N, D329N, D353N, D363N, D403N, D417N, D678N, D1457N, D1474N, D1502N, D1504N, D1526N, D1527N, D1541N, D315N, D334N, D361N, D372N, D394N, D396N, D401N, D439N, D464N, D1418N, D1435N, D1475N, D1476N, D1479N, D1518N, D1544N, D316N, D330N, D333N, D355N, D371N, D375N, D404N, D418N, D465N, D1249N, D1377N, D1419N, D1434N, D1456N, D1458N, D1477N, D1497N, D1503N, D1505N, D1519N, D1543N, D275N, D354N, D373N, D376N, D395N, D398N, D400N, D402N, D416N, D440N, D441N, D443N, D677N	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055245	17	41226387	17	43074370	55245	69912	rs28897691	NC_000017.11:43074369:C:T
NM_007294.4(BRCA1):c.4600G>A (p.Val1534Met)	BRCA1	V1534M, V1555M, V430M, V1487M, V1407M, V1421M, V1422M, V1486M, V1491M, V1506M, V1514M, V1530M, V1554M, V1556M, V383M, V392M, V1444M, V1445M, V1446M, V1464M, V1485M, V1493M, V1508M, V1515M, V1529M, V1531M, V263M, V303M, V321M, V341M, V359M, V361M, V363M, V382M, V388M, V389M, V391M, V428M, V429M, V666M, V1365M, V1406M, V1423M, V1462M, V1465M, V1467M, V1490M, V1532M, V317M, V349M, V351M, V360M, V364M, V384M, V390M, V406M, V427M, V431M, V452M, V665M, V1237M, V1463M, V1492M, V1507M, V1533M, V304M, V318M, V322M, V342M, V343M, V386M, V404M, V405M, V453M, V1238M, V1405M	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055235	17	41226423	17	43074406	55235	69902	rs55815649	NC_000017.11:43074405:C:T
NM_007294.4(BRCA1):c.4535G>T (p.Ser1512Ile)	BRCA1	S1512I, S408I, S1533I, S1465I, S1343I, S1385I, S1441I, S1442I, S1468I, S1492I, S1508I, S1509I, S1510I, S296I, S321I, S361I, S366I, S370I, S383I, S409I, S644I, S1215I, S1422I, S1423I, S1440I, S1445I, S1463I, S1464I, S1471I, S1493I, S1507I, S241I, S282I, S327I, S329I, S337I, S341I, S342I, S362I, S367I, S384I, S407I, S430I, S1383I, S1400I, S1401I, S1443I, S1469I, S1484I, S1485I, S1486I, S1511I, S1534I, S281I, S299I, S338I, S364I, S369I, S382I, S405I, S406I, S431I, S1216I, S1384I, S1399I, S1424I, S1470I, S1532I, S295I, S300I, S319I, S320I, S339I, S360I, S368I, S643I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041826	17	41226488	17	43074471	41826	50265	rs1800744	NC_000017.11:43074470:C:A
NM_007294.4(BRCA1):c.4520G>C (p.Arg1507Thr)	BRCA1	R1507T, R1460T, R1528T, R403T, R1418T, R1437T, R1458T, R1459T, R1464T, R1465T, R1479T, R1487T, R1488T, R1504T, R1506T, R277T, R315T, R332T, R333T, R355T, R356T, R378T, R379T, R426T, R1210T, R1338T, R1379T, R1380T, R1395T, R1436T, R1466T, R1480T, R1503T, R1529T, R236T, R314T, R324T, R334T, R361T, R362T, R400T, R404T, R425T, R638T, R639T, R1378T, R1419T, R1438T, R1440T, R1463T, R1502T, R1505T, R1527T, R290T, R316T, R322T, R337T, R357T, R363T, R377T, R401T, R402T, R1211T, R1394T, R1396T, R1417T, R1435T, R1481T, R276T, R291T, R294T, R295T, R336T, R359T, R364T, R365T	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000041825	17	41226503	17	43074486	41825	50264	rs80357470	NC_000017.11:43074485:C:G
NM_007294.4(BRCA1):c.4402A>C (p.Asn1468His)	BRCA1	N1468H, N1421H, N1489H, N364H, N1299H, N1355H, N1357H, N1396H, N1398H, N1420H, N1425H, N1440H, N238H, N251H, N275H, N297H, N298H, N317H, N339H, N1339H, N1340H, N1378H, N1380H, N1397H, N1399H, N1401H, N1426H, N1427H, N1449H, N237H, N276H, N294H, N322H, N323H, N326H, N338H, N362H, N365H, N387H, N600H, N1171H, N1379H, N1419H, N1441H, N1448H, N1463H, N1467H, N1490H, N197H, N255H, N277H, N285H, N293H, N295H, N320H, N340H, N361H, N599H, N1172H, N1341H, N1356H, N1424H, N1442H, N1464H, N1465H, N1466H, N1488H, N252H, N256H, N283H, N316H, N318H, N324H, N325H, N363H, N386H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055193	17	41228587	17	43076570	55193	69860	rs80357022	NC_000017.11:43076569:T:G
NM_007294.4(BRCA1):c.4327C>G (p.Arg1443Gly)	BRCA1	R1443G, R340G, R1396G, R1353G, R1372G, R1395G, R1415G, R1416G, R213G, R229G, R259G, R272G, R299G, R574G, R1315G, R1332G, R1373G, R1375G, R1394G, R1400G, R1402G, R1439G, R212G, R251G, R269G, R270G, R300G, R313G, R338G, R1316G, R1330G, R1331G, R1417G, R1442G, R227G, R252G, R293G, R314G, R339G, R575G, R1147G, R1274G, R1354G, R1355G, R1371G, R1376G, R1401G, R1441G, R172G, R230G, R231G, R260G, R273G, R291G, R292G, R295G, R298G, R301G, R337G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000017676	17	41234451	17	43082434	17676	32715	rs41293455	NC_000017.11:43082433:G:C
NM_007294.4(BRCA1):c.4255G>C (p.Glu1419Gln)	BRCA1	E1419Q, E316Q, E1372Q, E1329Q, E1347Q, E1378Q, E206Q, E228Q, E235Q, E267Q, E315Q, E550Q, E1123Q, E1291Q, E1306Q, E1308Q, E1348Q, E1349Q, E1377Q, E1391Q, E1392Q, E189Q, E205Q, E248Q, E249Q, E271Q, E276Q, E290Q, E313Q, E314Q, E1307Q, E1330Q, E1370Q, E1418Q, E148Q, E236Q, E245Q, E277Q, E551Q, E1250Q, E1292Q, E1331Q, E1351Q, E1352Q, E1371Q, E1376Q, E1393Q, E1415Q, E1417Q, E188Q, E203Q, E207Q, E227Q, E246Q, E268Q, E269Q, E274Q, E275Q, E289Q	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055154	17	41234523	17	43082506	55154	69821	rs80357309	NC_000017.11:43082505:C:G
NM_007294.4(BRCA1):c.4204C>T (p.His1402Tyr)	BRCA1	H1402Y, H299Y, H1355Y, H1233Y, H1275Y, H1289Y, H1312Y, H1314Y, H1330Y, H1334Y, H1335Y, H257Y, H260Y, H298Y, H1291Y, H1331Y, H1353Y, H1361Y, H1374Y, H1376Y, H171Y, H186Y, H190Y, H210Y, H211Y, H218Y, H232Y, H250Y, H251Y, H297Y, H533Y, H1106Y, H1290Y, H1313Y, H131Y, H1375Y, H1398Y, H1400Y, H172Y, H189Y, H219Y, H228Y, H229Y, H252Y, H254Y, H259Y, H272Y, H1274Y, H1332Y, H1354Y, H1359Y, H1360Y, H1401Y, H188Y, H231Y, H258Y, H273Y, H296Y, H534Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055140	17	41234574	17	43082557	55140	69807	rs80357365	NC_000017.11:43082556:G:A
NM_007294.4(BRCA1):c.4132G>A (p.Val1378Ile)	BRCA1	V1378I, V1331I, V275I, V1267I, V1307I, V1310I, V1330I, V1337I, V1351I, V194I, V230I, V236I, V249I, V107I, V1210I, V1250I, V1266I, V1311I, V147I, V164I, V166I, V187I, V205I, V207I, V227I, V233I, V235I, V510I, V1308I, V1336I, V1352I, V163I, V204I, V208I, V228I, V272I, V273I, V274I, V1082I, V1251I, V1289I, V1290I, V1375I, V1377I, V148I, V186I, V195I, V234I, V248I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055111	17	41243014	17	43090997	55111	69778	rs28897690	NC_000017.11:43090996:C:T
NM_007294.4(BRCA1):c.4081A>T (p.Met1361Leu)	BRCA1|LOC126862571	M1361L, M1314L, M1233L, M1272L, M1290L, M1313L, M1273L, M1319L, M1335L, M1358L, M1065L, M1250L, M1291L, M1294L, M1334L, M1360L, M1193L, M1234L, M1249L, M1293L, M1320L, M493L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000812551	17	41243467	17	43091450	812551	800791	rs80357218	NC_000017.11:43091449:T:A
NM_007294.4(BRCA1):c.4081A>C (p.Met1361Leu)	BRCA1|LOC126862571	M1361L, M1314L, M1065L, M1233L, M1293L, M1335L, M1234L, M1249L, M1250L, M1273L, M1291L, M1358L, M1360L, M1290L, M1313L, M1334L, M1193L, M1272L, M1294L, M1319L, M1320L, M493L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055099	17	41243467	17	43091450	55099	69766	rs80357218	NC_000017.11:43091449:T:G
NM_007294.4(BRCA1):c.4046C>T (p.Thr1349Met)	BRCA1|LOC126862571	T1349M, T1302M, T1237M, T1278M, T1301M, T1221M, T1261M, T1279M, T1282M, T1307M, T1322M, T481M, T1053M, T1260M, T1323M, T1348M, T1181M, T1222M, T1238M, T1281M, T1308M, T1346M	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055085	17	41243502	17	43091485	55085	69752	rs80357345	NC_000017.11:43091484:G:A
NM_007294.4(BRCA1):c.4039A>G (p.Arg1347Gly)	BRCA1|LOC126862571	R1347G, R1300G, R1321G, R1344G, R479G, R1179G, R1220G, R1258G, R1279G, R1299G, R1305G, R1320G, R1051G, R1235G, R1236G, R1259G, R1277G, R1306G, R1346G, R1219G, R1276G, R1280G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041821	17	41243509	17	43091492	41821	50260	rs28897689	NC_000017.11:43091491:T:C
NM_007294.4(BRCA1):c.4036G>A (p.Glu1346Lys)	BRCA1|LOC126862571	E1346K, E1299K, E1050K, E1178K, E1275K, E1276K, E1218K, E1258K, E1305K, E1235K, E1279K, E1298K, E1304K, E1345K, E1219K, E1234K, E1257K, E1278K, E1319K, E1320K, E1343K, E478K	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Aug 15, 2023)	criteria provided, multiple submitters, no conflicts	VCV000037561	17	41243512	17	43091495	37561	46117	rs80357407	NC_000017.11:43091494:C:T
NM_007294.4(BRCA1):c.3958T>C (p.Ser1320Pro)	BRCA1|LOC126862571	S1320P, S1273P, S1192P, S1250P, S1278P, S1293P, S1294P, S1317P, S1209P, S1231P, S1252P, S1253P, S1279P, S452P, S1024P, S1152P, S1193P, S1208P, S1232P, S1249P, S1272P, S1319P	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jan 1, 2000)	no assertion criteria provided	VCV000125659	17	41243590	17	43091573	125659	131197	rs80356855	NC_000017.11:43091572:A:G
NM_007294.4(BRCA1):c.3823A>G (p.Ile1275Val)	BRCA1|LOC126862571	I1275V, I1228V, I1107V, I1147V, I1205V, I1227V, I1233V, I407V, I1164V, I1187V, I1204V, I1208V, I1274V, I1148V, I1207V, I1234V, I1248V, I979V, I1163V, I1186V, I1249V, I1272V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037549	17	41243725	17	43091708	37549	46105	rs80357280	NC_000017.11:43091707:T:C
NM_007294.4(BRCA1):c.3797G>C (p.Ser1266Thr)	BRCA1|LOC126862571	S1266T, S1219T, S1138T, S1178T, S1195T, S1196T, S1224T, S1263T, S398T, S970T, S1139T, S1154T, S1155T, S1225T, S1239T, S1240T, S1098T, S1177T, S1198T, S1218T, S1199T, S1265T	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055009	17	41243751	17	43091734	55009	69676	rs80357160	NC_000017.11:43091733:C:G
NM_007294.4(BRCA1):c.3748G>A (p.Glu1250Lys)	BRCA1|LOC126862571	E1250K, E1203K, E1122K, E1182K, E1183K, E1208K, E1249K, E1138K, E1161K, E1162K, E382K, E1082K, E1123K, E1139K, E1179K, E1180K, E1209K, E1223K, E1247K, E1202K, E1224K, E954K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054987	17	41243800	17	43091783	54987	69654	rs28897686	NC_000017.11:43091782:C:T
NM_007294.4(BRCA1):c.3739G>A (p.Val1247Ile)	BRCA1|LOC126862571	V1247I, V1200I, V1119I, V1136I, V1179I, V1220I, V1221I, V1158I, V1176I, V1177I, V1180I, V1206I, V1246I, V1079I, V1199I, V1205I, V379I, V1120I, V1135I, V1159I, V1244I, V951I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054985	17	41243809	17	43091792	54985	69652	rs80357191	NC_000017.11:43091791:C:T
NM_007294.4(BRCA1):c.3724A>G (p.Thr1242Ala)	BRCA1|LOC126862571	T1242A, T1195A, T1172A, T1174A, T1194A, T1201A, T1215A, T946A, T1074A, T1115A, T1131A, T1171A, T1175A, T1216A, T374A, T1130A, T1153A, T1241A, T1114A, T1154A, T1200A, T1239A	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054982	17	41243824	17	43091807	54982	69649	rs80357037	NC_000017.11:43091806:T:C
NM_007294.4(BRCA1):c.3713C>T (p.Pro1238Leu)	BRCA1|LOC126862571	P1238L, P1191L, P1070L, P1127L, P1196L, P942L, P1149L, P1171L, P1197L, P1211L, P370L, P1126L, P1150L, P1168L, P1190L, P1110L, P1111L, P1167L, P1170L, P1212L, P1235L, P1237L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037543	17	41243835	17	43091818	37543	46099	rs28897688	NC_000017.11:43091817:G:A
NM_007294.4(BRCA1):c.3708T>G (p.Asn1236Lys)	BRCA1|LOC126862571	N1236K, N1189K, N1108K, N1109K, N1125K, N1148K, N1165K, N1209K, N1210K, N1068K, N1168K, N1188K, N1233K, N368K, N940K, N1147K, N1194K, N1195K, N1124K, N1166K, N1169K, N1235K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054970	17	41243840	17	43091823	54970	69637	rs28897687	NC_000017.11:43091822:A:C
NM_007294.4(BRCA1):c.3657G>T (p.Glu1219Asp)	BRCA1|LOC126862571	E1051D, E1107D, E1192D, E1219D, E351D, E1108D, E1148D, E1151D, E1152D, E1177D, E1178D, E1092D, E1130D, E1149D, E1171D, E1172D, E1193D, E1091D, E1131D, E1216D, E1218D, E923D	Hereditary breast ovarian cancer syndrome	Benign(Last reviewed: Oct 14, 2022)	criteria provided, single submitter	VCV002035518	17	41243891	17	43091874	2035518	2097302		NC_000017.11:43091873:C:A
NM_007294.4(BRCA1):c.3657G>C (p.Glu1219Asp)	BRCA1|LOC126862571	E1219D, E1172D, E1051D, E1091D, E1092D, E1149D, E1171D, E1178D, E1216D, E351D, E1131D, E1177D, E1192D, E1218D, E1107D, E1151D, E1193D, E923D, E1108D, E1130D, E1148D, E1152D	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037537	17	41243891	17	43091874	37537	46093	rs80356876	NC_000017.11:43091873:C:G
NM_007294.4(BRCA1):c.3640G>A (p.Glu1214Lys)	BRCA1|LOC126862571	E1214K, E1167K, E1125K, E1126K, E1146K, E1147K, E1173K, E1188K, E1211K, E1172K, E1187K, E918K, E1086K, E1087K, E1102K, E1103K, E1166K, E1213K, E1046K, E1143K, E1144K, E346K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054948	17	41243908	17	43091891	54948	69615	rs80356923	NC_000017.11:43091890:C:T
NM_007294.4(BRCA1):c.3608G>A (p.Arg1203Gln)	BRCA1|LOC126862571	R1203Q, R1156Q, R1133Q, R1162Q, R1176Q, R1177Q, R1200Q, R1202Q, R907Q, R1035Q, R1132Q, R1135Q, R1136Q, R1075Q, R1076Q, R1092Q, R1115Q, R1155Q, R1161Q, R335Q, R1091Q, R1114Q	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054935	17	41243940	17	43091923	54935	69602	rs55930959	NC_000017.11:43091922:C:T
NM_007294.4(BRCA1):c.3601G>A (p.Gly1201Ser)	BRCA1|LOC126862571	G1201S, G1154S, G1089S, G1090S, G1112S, G1131S, G1153S, G1175S, G1200S, G905S, G1073S, G1113S, G1134S, G1174S, G1198S, G1033S, G1074S, G1130S, G1133S, G1159S, G333S, G1160S	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|not provided	Benign/Likely benign(Last reviewed: Jun 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000054932	17	41243947	17	43091930	54932	69599	rs55725337	NC_000017.11:43091929:C:T
NM_007294.4(BRCA1):c.3600G>T (p.Gln1200His)	BRCA1|LOC126862571	Q1200H, Q1153H, Q1158H, Q1159H, Q1173H, Q1174H, Q1032H, Q1112H, Q1132H, Q1197H, Q1199H, Q1089H, Q1072H, Q1073H, Q1088H, Q1133H, Q332H, Q904H, Q1111H, Q1129H, Q1130H, Q1152H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054931	17	41243948	17	43091931	54931	69598	rs56214134	NC_000017.11:43091930:C:A
NM_007294.4(BRCA1):c.3600G>C (p.Gln1200His)	BRCA1|LOC126862571	Q1200H, Q1153H, Q1072H, Q1112H, Q1129H, Q1130H, Q1133H, Q1174H, Q1199H, Q1073H, Q1088H, Q1152H, Q1158H, Q1159H, Q1173H, Q1197H, Q332H, Q1032H, Q1089H, Q1111H, Q1132H, Q904H	not specified|Breast-ovarian cancer, familial, susceptibility to, 1|Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome|not provided	Benign/Likely benign(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000054930	17	41243948	17	43091931	54930	69597	rs56214134	NC_000017.11:43091930:C:G
NM_007294.4(BRCA1):c.3548A>G (p.Lys1183Arg)	BRCA1|LOC126862571	K1183R, K1136R, K1056R, K1113R, K1115R, K1182R, K1055R, K1141R, K1015R, K1072R, K1094R, K1095R, K1116R, K1157R, K315R, K887R, K1071R, K1112R, K1135R, K1142R, K1156R, K1180R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041818	17	41244000	17	43091983	41818	50257	rs16942	NC_000017.11:43091982:T:C
NM_007294.4(BRCA1):c.3541G>A (p.Val1181Ile)	BRCA1|LOC126862571	V1181I, V1134I, V1053I, V1093I, V1110I, V1111I, V1133I, V1178I, V1013I, V1069I, V1092I, V1154I, V1054I, V1070I, V1113I, V1139I, V1155I, V1180I, V885I, V313I, V1114I, V1140I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054911	17	41244007	17	43091990	54911	69578	rs56336919	NC_000017.11:43091989:C:T
NM_007294.4(BRCA1):c.3463G>C (p.Asp1155His)	BRCA1|LOC126862571	D1155H, D1108H, D1066H, D1128H, D1152H, D987H, D1027H, D1043H, D1085H, D1114H, D1129H, D859H, D1113H, D1028H, D1044H, D1067H, D1084H, D1087H, D1088H, D1107H, D1154H, D287H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054891	17	41244085	17	43092068	54891	69558	rs80357484	NC_000017.11:43092067:C:G
NM_007294.4(BRCA1):c.3448C>T (p.Pro1150Ser)	BRCA1|LOC126862571	P1150S, P1103S, P1022S, P1039S, P282S, P1023S, P1038S, P1062S, P1082S, P1109S, P1147S, P1061S, P1102S, P1108S, P1124S, P1079S, P1080S, P1083S, P1123S, P1149S, P854S, P982S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054887	17	41244100	17	43092083	54887	69554	rs80357272	NC_000017.11:43092082:G:A
NM_007294.4(BRCA1):c.3418A>G (p.Ser1140Gly)	BRCA1|LOC126862571	S1140G, S1093G, S1029G, S1051G, S1069G, S1092G, S1114G, S972G, S1013G, S1028G, S1072G, S1099G, S844G, S1012G, S1070G, S1098G, S1113G, S1139G, S272G, S1052G, S1073G, S1137G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041817	17	41244130	17	43092113	41817	50256	rs2227945	NC_000017.11:43092112:T:C
NM_007294.4(BRCA1):c.3416G>T (p.Ser1139Ile)	BRCA1|LOC126862571	S1139I, S1092I, S1051I, S1072I, S1091I, S1011I, S1012I, S1027I, S1112I, S1136I, S843I, S971I, S1028I, S1050I, S1097I, S1138I, S271I, S1068I, S1069I, S1071I, S1098I, S1113I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054873	17	41244132	17	43092115	54873	69540	rs80357228	NC_000017.11:43092114:C:A
NM_007294.4(BRCA1):c.3327A>C (p.Lys1109Asn)	BRCA1|LOC126862571	K1109N, K1062N, K1061N, K1067N, K1108N, K1039N, K1042N, K1021N, K1068N, K1083N, K813N, K981N, K1020N, K1038N, K1041N, K1082N, K1106N, K941N, K982N, K997N, K998N	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037522	17	41244221	17	43092204	37522	46078	rs41293449	NC_000017.11:43092203:T:G
NM_007294.4(BRCA1):c.3302G>A (p.Ser1101Asn)	BRCA1|LOC126862571	S1101N, S1054N, S1013N, S1030N, S1034N, S1060N, S1100N, S973N, S989N, S933N, S1059N, S1074N, S1075N, S1098N, S1012N, S1031N, S1033N, S1053N, S805N, S974N, S990N	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054830	17	41244246	17	43092229	54830	69497	rs41293447	NC_000017.11:43092228:C:T
NM_007294.4(BRCA1):c.3296C>T (p.Pro1099Leu)	BRCA1|LOC126862571	P1099L, P1052L, P1031L, P1058L, P1098L, P972L, P1010L, P1011L, P1051L, P1057L, P1096L, P971L, P987L, P1028L, P1029L, P1032L, P1072L, P803L, P931L, P1073L, P988L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041816	17	41244252	17	43092235	41816	50255	rs80357201	NC_000017.11:43092234:G:A
NM_007294.4(BRCA1):c.3143G>T (p.Gly1048Val)	BRCA1	G1048V, G1001V, G1007V, G1022V, G1045V, G1047V, G960V, G980V, G1000V, G936V, G937V, G978V, G880V, G1006V, G1021V, G752V, G920V, G921V, G959V, G977V, G981V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054777	17	41244405	17	43092388	54777	69444	rs80356899	NC_000017.11:43092387:C:A
NM_007294.4(BRCA1):c.3130A>G (p.Ile1044Val)	BRCA1	I1044V, I997V, I1017V, I1018V, I1041V, I917V, I932V, I973V, I974V, I1002V, I1003V, I955V, I976V, I876V, I916V, I933V, I956V, I1043V, I748V, I977V, I996V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037510	17	41244418	17	43092401	37510	46066	rs80357271	NC_000017.11:43092400:T:C
NM_007294.4(BRCA1):c.3119G>A (p.Ser1040Asn)	BRCA1	S1040N, S993N, S1014N, S1039N, S992N, S998N, S872N, S913N, S929N, S969N, S1013N, S928N, S972N, S973N, S1037N, S744N, S912N, S951N, S952N, S970N, S999N	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000017670	17	41244429	17	43092412	17670	32709	rs4986852	NC_000017.11:43092411:C:T
NM_007294.4(BRCA1):c.3113A>G (p.Glu1038Gly)	BRCA1	E1038G, E991G, E1012G, E742G, E870G, E927G, E971G, E996G, E949G, E911G, E926G, E950G, E967G, E970G, E990G, E1011G, E1035G, E1037G, E910G, E968G, E997G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041815	17	41244435	17	43092418	41815	50254	rs16941	NC_000017.11:43092417:T:C
NM_007294.4(BRCA1):c.3083G>A (p.Arg1028His)	BRCA1	R1028H, R981H, R1001H, R916H, R940H, R957H, R980H, R986H, R860H, R901H, R917H, R1027H, R900H, R960H, R961H, R1002H, R1025H, R732H, R939H, R958H, R987H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037507	17	41244465	17	43092448	37507	46063	rs80357459	NC_000017.11:43092447:C:T
NM_007294.4(BRCA1):c.3082C>T (p.Arg1028Cys)	BRCA1	R1028C, R981C, R1002C, R901C, R940C, R957C, R980C, R987C, R1025C, R958C, R732C, R860C, R900C, R916C, R917C, R939C, R961C, R986C, R1001C, R1027C, R960C	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037506	17	41244466	17	43092449	37506	46062	rs80357049	NC_000017.11:43092448:G:A
NM_007294.4(BRCA1):c.3024G>A (p.Met1008Ile)	BRCA1	M1008I, M961I, M881I, M938I, M940I, M960I, M982I, M712I, M840I, M897I, M941I, M981I, M1005I, M880I, M919I, M920I, M937I, M966I, M967I, M1007I, M896I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041814	17	41244524	17	43092507	41814	50253	rs1800704	NC_000017.11:43092506:C:T
NM_007294.4(BRCA1):c.3022A>G (p.Met1008Val)	BRCA1	M1008V, M961V, M897V, M966V, M967V, M1005V, M712V, M937V, M938V, M982V, M840V, M896V, M941V, M981V, M1007V, M880V, M881V, M919V, M920V, M940V, M960V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054755	17	41244526	17	43092509	54755	69422	rs56321129	NC_000017.11:43092508:T:C
NM_007294.4(BRCA1):c.2912A>G (p.His971Arg)	BRCA1	H971R, H924R, H803R, H883R, H901R, H903R, H675R, H844R, H882R, H904R, H929R, H970R, H843R, H860R, H923R, H968R, H859R, H900R, H930R, H944R, H945R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000628452	17	41244636	17	43092619	628452	618626	rs1567793641	NC_000017.11:43092618:T:C
NM_007294.4(BRCA1):c.2884G>A (p.Glu962Lys)	BRCA1	E962K, E915K, E834K, E835K, E851K, E873K, E794K, E920K, E921K, E935K, E666K, E850K, E891K, E894K, E936K, E874K, E892K, E895K, E914K, E959K, E961K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054709	17	41244664	17	43092647	54709	69376	rs80356955	NC_000017.11:43092646:C:T
NM_007294.4(BRCA1):c.2798G>C (p.Gly933Ala)	BRCA1	G933A, G886A, G821A, G885A, G907A, G637A, G805A, G844A, G845A, G865A, G866A, G930A, G765A, G822A, G863A, G891A, G906A, G932A, G806A, G862A, G892A	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000233288	17	41244750	17	43092733	233288	236054	rs80356941	NC_000017.11:43092732:C:G
NM_007294.4(BRCA1):c.2773A>C (p.Ile925Leu)	BRCA1	I925L, I878L, I629L, I798L, I837L, I883L, I898L, I922L, I813L, I836L, I854L, I797L, I814L, I857L, I899L, I757L, I855L, I858L, I877L, I884L, I924L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037489	17	41244775	17	43092758	37489	46045	rs4986847	NC_000017.11:43092757:T:G
NM_007294.4(BRCA1):c.2758G>A (p.Val920Ile)	BRCA1	V920I, V873I, V808I, V852I, V872I, V624I, V793I, V850I, V809I, V831I, V849I, V878I, V917I, V853I, V893I, V894I, V919I, V752I, V792I, V832I, V879I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037488	17	41244790	17	43092773	37488	46044	rs80357361	NC_000017.11:43092772:C:T
NM_007294.4(BRCA1):c.2669G>T (p.Gly890Val)	BRCA1	G890V, G843V, G594V, G762V, G820V, G823V, G849V, G887V, G889V, G722V, G779V, G802V, G819V, G822V, G863V, G763V, G778V, G801V, G842V, G848V, G864V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037479	17	41244879	17	43092862	37479	46035	rs80356874	NC_000017.11:43092861:C:A
NM_007294.4(BRCA1):c.2612C>T (p.Pro871Leu)	BRCA1	P871L, P824L, P703L, P743L, P801L, P803L, P845L, P744L, P782L, P783L, P800L, P868L, P804L, P829L, P830L, P844L, P575L, P759L, P760L, P823L, P870L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041812	17	41244936	17	43092919	41812	50251	rs799917	NC_000017.11:43092918:G:A
NM_007294.4(BRCA1):c.2597G>A (p.Arg866His)	BRCA1	R866H, R819H, R738H, R755H, R795H, R824H, R839H, R863H, R799H, R570H, R739H, R754H, R777H, R818H, R825H, R840H, R865H, R698H, R778H, R796H, R798H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054613	17	41244951	17	43092934	54613	69280	rs80356911	NC_000017.11:43092933:C:T
NM_007294.4(BRCA1):c.2596C>T (p.Arg866Cys)	BRCA1	R866C, R819C, R738C, R754C, R755C, R778C, R798C, R799C, R865C, R570C, R777C, R796C, R825C, R698C, R795C, R824C, R839C, R739C, R818C, R840C, R863C	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041811	17	41244952	17	43092935	41811	50250	rs41286300	NC_000017.11:43092934:G:A
NM_007294.4(BRCA1):c.2584A>G (p.Lys862Glu)	BRCA1	K862E, K815E, K773E, K792E, K794E, K566E, K735E, K795E, K820E, K861E, K694E, K734E, K750E, K751E, K774E, K791E, K836E, K859E, K814E, K821E, K835E	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037476	17	41244964	17	43092947	37476	46032	rs80356927	NC_000017.11:43092946:T:C
NM_007294.4(BRCA1):c.2566T>C (p.Tyr856His)	BRCA1	Y856H, Y809H, Y786H, Y808H, Y728H, Y768H, Y814H, Y815H, Y829H, Y767H, Y830H, Y853H, Y560H, Y688H, Y729H, Y744H, Y745H, Y785H, Y788H, Y789H, Y855H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054604	17	41244982	17	43092965	54604	69271	rs80356892	NC_000017.11:43092964:A:G
NM_007294.4(BRCA1):c.2525A>G (p.Glu842Gly)	BRCA1	E842G, E795G, E731G, E753G, E841G, E771G, E774G, E775G, E801G, E839G, E546G, E674G, E754G, E794G, E800G, E815G, E714G, E715G, E730G, E772G, E816G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000091592	17	41245023	17	43093006	91592	97069	rs28897684	NC_000017.11:43093005:T:C
NM_007294.4(BRCA1):c.2522G>A (p.Arg841Gln)	BRCA1	R841Q, R794Q, R714Q, R729Q, R773Q, R799Q, R800Q, R673Q, R753Q, R793Q, R815Q, R545Q, R713Q, R730Q, R770Q, R771Q, R752Q, R774Q, R814Q, R838Q, R840Q	Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Breast-ovarian cancer, familial, susceptibility to, 1|not provided	Benign/Likely benign(Last reviewed: Jun 1, 2023)	criteria provided, multiple submitters, no conflicts	VCV000054591	17	41245026	17	43093009	54591	69258	rs80357337	NC_000017.11:43093008:C:T
NM_007294.4(BRCA1):c.2521C>T (p.Arg841Trp)	BRCA1	R841W, R794W, R840W, R673W, R730W, R752W, R799W, R838W, R545W, R713W, R770W, R773W, R814W, R815W, R729W, R753W, R771W, R800W, R714W, R774W, R793W	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000017681	17	41245027	17	43093010	17681	32720	rs1800709	NC_000017.11:43093009:G:A
NM_007294.4(BRCA1):c.2515C>T (p.His839Tyr)	BRCA1	H543Y, H671Y, H711Y, H712Y, H727Y, H728Y, H750Y, H751Y, H768Y, H769Y, H771Y, H772Y, H791Y, H792Y, H797Y, H798Y, H812Y, H813Y, H836Y, H838Y, H839Y	Ovarian cancer	Benign(Last reviewed: Jan 1, 2022)	criteria provided, single submitter	VCV002445306	17	41245033	17	43093016	2445306	2419032		NC_000017.11:43093015:G:A
NM_007294.4(BRCA1):c.2477C>A (p.Thr826Lys)	BRCA1	T826K, T779K, T738K, T755K, T784K, T800K, T530K, T715K, T737K, T759K, T658K, T698K, T758K, T778K, T799K, T825K, T699K, T714K, T756K, T785K, T823K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037473	17	41245071	17	43093054	37473	46029	rs28897683	NC_000017.11:43093053:G:T
NM_007294.4(BRCA1):c.2458A>G (p.Lys820Glu)	BRCA1	K820E, K773E, K524E, K753E, K779E, K817E, K693E, K708E, K732E, K750E, K794E, K652E, K709E, K731E, K749E, K772E, K778E, K793E, K692E, K752E, K819E	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041810	17	41245090	17	43093073	41810	50249	rs56082113	NC_000017.11:43093072:T:C
NM_007294.4(BRCA1):c.2428A>T (p.Asn810Tyr)	BRCA1	N810Y, N763Y, N642Y, N721Y, N722Y, N768Y, N769Y, N809Y, N699Y, N742Y, N762Y, N783Y, N784Y, N698Y, N514Y, N682Y, N683Y, N739Y, N740Y, N743Y, N807Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054567	17	41245120	17	43093103	54567	69234	rs28897682	NC_000017.11:43093102:T:A
NM_007294.4(BRCA1):c.2412G>C (p.Gln804His)	BRCA1	Q804H, Q757H, Q676H, Q693H, Q734H, Q778H, Q777H, Q803H, Q508H, Q636H, Q715H, Q756H, Q801H, Q677H, Q692H, Q716H, Q733H, Q736H, Q737H, Q762H, Q763H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054561	17	41245136	17	43093119	54561	69228	rs55746541	NC_000017.11:43093118:C:G
NM_007294.4(BRCA1):c.2351C>T (p.Ser784Leu)	BRCA1	S784L, S737L, S656L, S673L, S695L, S713L, S714L, S736L, S742L, S757L, S758L, S616L, S657L, S743L, S783L, S488L, S696L, S716L, S717L, S672L, S781L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037464	17	41245197	17	43093180	37464	46020	rs55914168	NC_000017.11:43093179:G:A
NM_007294.4(BRCA1):c.2335A>T (p.Thr779Ser)	BRCA1	T732S, T779S, T776S, T483S, T652S, T667S, T691S, T731S, T738S, T778S, T711S, T752S, T611S, T651S, T668S, T690S, T708S, T709S, T712S, T737S, T753S	Hereditary breast ovarian cancer syndrome	Benign(Last reviewed: Apr 19, 2022)	criteria provided, single submitter	VCV001325663	17	41245213	17	43093196	1325663	1315928		NC_000017.11:43093195:T:A
NM_007294.4(BRCA1):c.2315T>C (p.Val772Ala)	BRCA1	V772A, V725A, V476A, V684A, V702A, V724A, V731A, V771A, V604A, V644A, V660A, V661A, V730A, V746A, V745A, V769A, V645A, V683A, V701A, V704A, V705A	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041809	17	41245233	17	43093216	41809	50248	rs80357467	NC_000017.11:43093215:A:G
NM_007294.4(BRCA1):c.2286A>T (p.Arg762Ser)	BRCA1	R762S, R715S, R635S, R651S, R714S, R736S, R634S, R650S, R674S, R694S, R720S, R692S, R695S, R721S, R735S, R761S, R466S, R594S, R673S, R691S, R759S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054522	17	41245262	17	43093245	54522	69189	rs273898682	NC_000017.11:43093244:T:A
NM_007294.4(BRCA1):c.2207A>C (p.Glu736Ala)	BRCA1	E736A, E689A, E440A, E609A, E668A, E694A, E733A, E735A, E624A, E625A, E647A, E648A, E695A, E710A, E568A, E665A, E688A, E608A, E666A, E669A, E709A	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Jan 27, 2023)	criteria provided, multiple submitters, no conflicts	VCV000037455	17	41245341	17	43093324	37455	46011	rs397507196	NC_000017.11:43093323:T:G
NM_007294.4(BRCA1):c.2180C>T (p.Pro727Leu)	BRCA1	P727L, P680L, P599L, P639L, P659L, P660L, P615L, P657L, P686L, P724L, P726L, P431L, P559L, P600L, P700L, P701L, P616L, P638L, P656L, P679L, P685L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054486	17	41245368	17	43093351	54486	69153	rs80356912	NC_000017.11:43093350:G:A
NM_007294.4(BRCA1):c.2167A>G (p.Asn723Asp)	BRCA1	N723D, N676D, N596D, N611D, N696D, N722D, N612D, N656D, N427D, N595D, N635D, N652D, N655D, N682D, N697D, N555D, N634D, N653D, N675D, N681D, N720D	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037454	17	41245381	17	43093364	37454	46010	rs4986845	NC_000017.11:43093363:T:C
NM_007294.4(BRCA1):c.2083G>T (p.Asp695Tyr)	BRCA1	D695Y, D648Y, D527Y, D567Y, D583Y, D584Y, D628Y, D668Y, D653Y, D654Y, D399Y, D607Y, D627Y, D669Y, D568Y, D606Y, D624Y, D625Y, D647Y, D692Y, D694Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054456	17	41245465	17	43093448	54456	69123	rs28897681	NC_000017.11:43093447:C:A
NM_007294.4(BRCA1):c.2077G>T (p.Asp693Tyr)	BRCA1	D693Y, D646Y, D605Y, D625Y, D626Y, D666Y, D690Y, D397Y, D565Y, D581Y, D645Y, D692Y, D525Y, D566Y, D582Y, D623Y, D651Y, D652Y, D604Y, D622Y, D667Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Dec 17, 2010)	no assertion criteria provided	VCV000125534	17	41245471	17	43093454	125534	131072	rs4986850	NC_000017.11:43093453:C:A
NM_007294.4(BRCA1):c.2077G>A (p.Asp693Asn)	BRCA1	D693N, D646N, D582N, D605N, D622N, D652N, D690N, D397N, D565N, D581N, D626N, D651N, D692N, D525N, D566N, D645N, D666N, D604N, D623N, D625N, D667N	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041808	17	41245471	17	43093454	41808	50247	rs4986850	NC_000017.11:43093453:C:T
NM_007294.4(BRCA1):c.2002C>T (p.Leu668Phe)	BRCA1	L668F, L621F, L541F, L665F, L500F, L556F, L579F, L580F, L600F, L627F, L641F, L540F, L598F, L601F, L620F, L667F, L372F, L557F, L597F, L626F, L642F	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037441	17	41245546	17	43093529	37441	45997	rs80357250	NC_000017.11:43093528:G:A
NM_007294.4(BRCA1):c.1974G>A (p.Met658Ile)	BRCA1	M611I, M658I, M546I, M547I, M655I, M362I, M531I, M591I, M490I, M569I, M570I, M587I, M588I, M617I, M632I, M530I, M590I, M610I, M616I, M631I, M657I	Hereditary breast ovarian cancer syndrome	Benign(Last reviewed: Aug 14, 2020)	criteria provided, single submitter	VCV001168433	17	41245574	17	43093557	1168433	1157986		NC_000017.11:43093556:C:T
NM_007294.4(BRCA1):c.1927A>G (p.Ser643Gly)	BRCA1	S643G, S596G, S347G, S516G, S572G, S595G, S617G, S554G, S576G, S602G, S531G, S616G, S642G, S475G, S515G, S532G, S555G, S573G, S575G, S601G, S640G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054402	17	41245621	17	43093604	54402	69069	rs80357105	NC_000017.11:43093603:T:C
NM_007294.4(BRCA1):c.1924G>C (p.Asp642His)	BRCA1	D642H, D595H, D572H, D639H, D641H, D514H, D531H, D594H, D616H, D346H, D515H, D553H, D571H, D574H, D575H, D600H, D474H, D530H, D554H, D601H, D615H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054401	17	41245624	17	43093607	54401	69068	rs80357344	NC_000017.11:43093606:C:G
NM_007294.4(BRCA1):c.1865C>T (p.Ala622Val)	BRCA1	A622V, A575V, A326V, A454V, A495V, A555V, A580V, A581V, A595V, A596V, A511V, A533V, A551V, A552V, A621V, A510V, A554V, A619V, A494V, A534V, A574V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054371	17	41245683	17	43093666	54371	69038	rs56039126	NC_000017.11:43093665:G:A
NM_007294.4(BRCA1):c.1834A>G (p.Arg612Gly)	BRCA1	R612G, R565G, R500G, R571G, R611G, R524G, R545G, R564G, R570G, R586G, R316G, R484G, R542G, R585G, R444G, R485G, R501G, R523G, R541G, R544G, R609G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054367	17	41245714	17	43093697	54367	69034	rs80357245	NC_000017.11:43093696:T:C
NM_007294.4(BRCA1):c.1789G>A (p.Glu597Lys)	BRCA1	E597K, E550K, E301K, E527K, E469K, E470K, E508K, E530K, E596K, E429K, E486K, E555K, E570K, E571K, E594K, E485K, E509K, E526K, E529K, E549K, E556K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041806	17	41245759	17	43093742	41806	50245	rs55650082	NC_000017.11:43093741:C:T
NM_007294.4(BRCA1):c.1703C>T (p.Pro568Leu)	BRCA1	P568L, P521L, P441L, P541L, P456L, P479L, P497L, P520L, P527L, P542L, P565L, P480L, P498L, P500L, P567L, P272L, P400L, P440L, P457L, P501L, P526L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054329	17	41245845	17	43093828	54329	68996	rs80356910	NC_000017.11:43093827:G:A
NM_007294.4(BRCA1):c.1648A>C (p.Asn550His)	BRCA1	N550H, N503H, N461H, N482H, N254H, N382H, N479H, N483H, N508H, N523H, N439H, N480H, N502H, N524H, N422H, N423H, N438H, N462H, N509H, N547H, N549H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037423	17	41245900	17	43093883	37423	45979	rs56012641	NC_000017.11:43093882:T:G
NM_007294.4(BRCA1):c.1616C>T (p.Thr539Met)	BRCA1	T539M, T492M, T371M, T412M, T469M, T512M, T513M, T538M, T411M, T471M, T472M, T498M, T427M, T450M, T468M, T497M, T243M, T428M, T451M, T491M, T536M	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054310	17	41245932	17	43093915	54310	68977	rs80357374	NC_000017.11:43093914:G:A
NM_007294.4(BRCA1):c.1534C>T (p.Leu512Phe)	BRCA1	L512F, L465F, L216F, L400F, L441F, L442F, L471F, L509F, L384F, L424F, L445F, L486F, L344F, L401F, L444F, L470F, L385F, L423F, L464F, L485F, L511F	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037420	17	41246014	17	43093997	37420	45976	rs41286294	NC_000017.11:43093996:G:A
NM_007294.4(BRCA1):c.1511G>A (p.Arg504His)	BRCA1	R504H, R457H, R415H, R433H, R434H, R456H, R463H, R208H, R336H, R377H, R392H, R462H, R376H, R436H, R477H, R501H, R393H, R416H, R437H, R478H, R503H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054278	17	41246037	17	43094020	54278	68945	rs56272539	NC_000017.11:43094019:C:T
NM_007294.4(BRCA1):c.1487G>A (p.Arg496His)	BRCA1	R496H, R449H, R385H, R408H, R425H, R428H, R495H, R328H, R368H, R426H, R448H, R469H, R200H, R369H, R455H, R470H, R384H, R407H, R429H, R454H, R493H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041805	17	41246061	17	43094044	41805	50244	rs28897677	NC_000017.11:43094043:C:T
NM_007294.4(BRCA1):c.1486C>T (p.Arg496Cys)	BRCA1	R496C, R449C, R200C, R454C, R384C, R407C, R455C, R493C, R495C, R328C, R408C, R426C, R428C, R448C, R469C, R368C, R369C, R385C, R425C, R429C, R470C	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037416	17	41246062	17	43094045	37416	45972	rs28897676	NC_000017.11:43094044:G:A
NM_007294.4(BRCA1):c.1458T>A (p.Phe486Leu)	BRCA1	F486L, F439L, F416L, F419L, F460L, F318L, F359L, F398L, F418L, F459L, F485L, F358L, F374L, F397L, F483L, F190L, F375L, F415L, F438L, F444L, F445L	Hereditary cancer-predisposing syndrome|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Sep 9, 2019)	criteria provided, multiple submitters, no conflicts	VCV000054259	17	41246090	17	43094073	54259	68926	rs80357400	NC_000017.11:43094072:A:T
NM_007294.4(BRCA1):c.1456T>C (p.Phe486Leu)	BRCA1	F486L, F439L, F374L, F375L, F416L, F419L, F444L, F358L, F398L, F438L, F483L, F318L, F397L, F415L, F485L, F190L, F359L, F418L, F445L, F459L, F460L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054258	17	41246092	17	43094075	54258	68925	rs55906931	NC_000017.11:43094074:A:G
NM_007294.4(BRCA1):c.1427A>G (p.His476Arg)	BRCA1	H476R, H429R, H364R, H434R, H449R, H180R, H308R, H365R, H388R, H405R, H406R, H428R, H450R, H475R, H349R, H409R, H473R, H348R, H387R, H408R, H435R	not specified|not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary breast ovarian cancer syndrome|Hereditary cancer-predisposing syndrome	Benign/Likely benign(Last reviewed: Oct 31, 2022)	criteria provided, multiple submitters, no conflicts	VCV000054251	17	41246121	17	43094104	54251	68918	rs55720177	NC_000017.11:43094103:T:C
NM_007294.4(BRCA1):c.1418A>T (p.Asn473Ile)	BRCA1	N473I, N426I, N345I, N346I, N361I, N385I, N432I, N470I, N177I, N384I, N402I, N405I, N447I, N472I, N362I, N406I, N431I, N305I, N403I, N425I, N446I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054249	17	41246130	17	43094113	54249	68916	rs80357057	NC_000017.11:43094112:T:A
NM_007294.4(BRCA1):c.1418A>G (p.Asn473Ser)	BRCA1	N473S, N426S, N177S, N384S, N405S, N406S, N345S, N361S, N402S, N431S, N432S, N446S, N472S, N362S, N403S, N425S, N305S, N346S, N385S, N447S, N470S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054248	17	41246130	17	43094113	54248	68915	rs80357057	NC_000017.11:43094112:T:C
NM_007294.4(BRCA1):c.1383T>A (p.Phe461Leu)	BRCA1	F461L, F414L, F419L, F458L, F460L, F334L, F372L, F373L, F394L, F413L, F435L, F293L, F333L, F349L, F390L, F391L, F393L, F434L, F165L, F350L, F420L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000054228	17	41246165	17	43094148	54228	68895	rs56046357	NC_000017.11:43094147:A:T
NM_007294.4(BRCA1):c.1233T>G (p.Asp411Glu)	BRCA1	D411E, D364E, D300E, D323E, D344E, D410E, D283E, D322E, D340E, D384E, D385E, D408E, D115E, D243E, D284E, D299E, D370E, D341E, D343E, D363E, D369E	Hereditary cancer-predisposing syndrome|not specified|not provided|Hereditary breast ovarian cancer syndrome	Benign/Likely benign(Last reviewed: Apr 7, 2023)	criteria provided, multiple submitters, no conflicts	VCV000041804	17	41246315	17	43094298	41804	50243	rs80357024	NC_000017.11:43094297:A:C
NM_007294.4(BRCA1):c.1198G>A (p.Asp400Asn)	BRCA1	D353N, D400N, D288N, D312N, D329N, D330N, D399N, D289N, D311N, D333N, D397N, D332N, D358N, D104N, D232N, D272N, D273N, D352N, D359N, D373N, D374N	Hereditary breast ovarian cancer syndrome	Benign(Last reviewed: Jul 5, 2022)	criteria provided, single submitter	VCV001060748	17	41246350	17	43094333	1060748	1050315		NC_000017.11:43094332:C:T
NM_007294.4(BRCA1):c.1159T>A (p.Ser387Thr)	BRCA1	S387T, S340T, S219T, S276T, S298T, S345T, S91T, S260T, S320T, S384T, S386T, S259T, S275T, S299T, S316T, S317T, S319T, S361T, S339T, S346T, S360T	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000231852	17	41246389	17	43094372	231852	236139	rs876659403	NC_000017.11:43094371:A:T
NM_007294.4(BRCA1):c.1137T>G (p.Ile379Met)	BRCA1	I379M, I332M, I291M, I309M, I337M, I352M, I353M, I267M, I268M, I290M, I338M, I378M, I83M, I211M, I251M, I252M, I308M, I311M, I312M, I331M, I376M	not provided|Breast-ovarian cancer, familial, susceptibility to, 1|Familial cancer of breast|Fanconi anemia, complementation group S|Breast-ovarian cancer, familial, susceptibility to, 1|Pancreatic cancer, susceptibility to, 4|Hereditary cancer-predisposing syndrome|not specified|Hereditary breast ovarian cancer syndrome|Familial cancer of breast	Benign/Likely benign(Last reviewed: Nov 15, 2022)	criteria provided, multiple submitters, no conflicts	VCV000054143	17	41246411	17	43094394	54143	68810	rs56128296	NC_000017.11:43094393:A:C
NM_007294.4(BRCA1):c.1105G>A (p.Asp369Asn)	BRCA1	D369N, D322N, D257N, D73N, D201N, D281N, D302N, D321N, D327N, D328N, D241N, D258N, D280N, D299N, D301N, D342N, D343N, D366N, D368N, D242N, D298N	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037390	17	41246443	17	43094426	37390	45946	rs56056711	NC_000017.11:43094425:C:T
NM_007294.4(BRCA1):c.1067A>G (p.Gln356Arg)	BRCA1	Q356R, Q309R, Q314R, Q315R, Q353R, Q244R, Q268R, Q288R, Q329R, Q355R, Q60R, Q228R, Q245R, Q267R, Q289R, Q188R, Q229R, Q285R, Q286R, Q308R, Q330R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041803	17	41246481	17	43094464	41803	50242	rs1799950	NC_000017.11:43094463:T:C
NM_007294.4(BRCA1):c.1036C>T (p.Pro346Ser)	BRCA1	P346S, P299S, P275S, P298S, P304S, P320S, P345S, P178S, P218S, P234S, P50S, P235S, P257S, P276S, P279S, P305S, P319S, P343S, P219S, P258S, P278S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037389	17	41246512	17	43094495	37389	45945	rs80357015	NC_000017.11:43094494:G:A
NM_007294.4(BRCA1):c.1001C>T (p.Pro334Leu)	BRCA1	P334L, P287L, P286L, P292L, P333L, P166L, P206L, P223L, P245L, P246L, P263L, P307L, P308L, P207L, P266L, P267L, P331L, P222L, P264L, P293L, P38L	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054099	17	41246547	17	43094530	54099	68766	rs41286290	NC_000017.11:43094529:G:A
NM_007294.4(BRCA1):c.997A>G (p.Thr333Ala)	BRCA1	T333A, T286A, T206A, T222A, T244A, T245A, T266A, T292A, T221A, T262A, T263A, T306A, T330A, T332A, T37A, T165A, T265A, T291A, T205A, T285A, T307A	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000184709	17	41246551	17	43094534	184709	185085	rs786201634	NC_000017.11:43094533:T:C
NM_007294.4(BRCA1):c.946A>G (p.Ser316Gly)	BRCA1	S316G, S269G, S148G, S20G, S245G, S289G, S227G, S274G, S315G, S204G, S268G, S275G, S290G, S313G, S188G, S189G, S205G, S228G, S246G, S248G, S249G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037709	17	41246602	17	43094585	37709	46265	rs55874646	NC_000017.11:43094584:T:C
NM_007294.4(BRCA1):c.891G>T (p.Met297Ile)	BRCA1	M297I, M250I, M169I, M208I, M227I, M230I, M249I, M186I, M1I, M209I, M226I, M256I, M270I, M294I, M129I, M255I, M271I, M170I, M185I, M229I, M296I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000812549	17	41246657	17	43094640	812549	800792	rs80357103	NC_000017.11:43094639:C:A
NM_007294.4(BRCA1):c.891G>A (p.Met297Ile)	BRCA1	M297I, M250I, M129I, M208I, M227I, M229I, M230I, M271I, M1I, M255I, M270I, M169I, M294I, M296I, M170I, M185I, M186I, M209I, M226I, M249I, M256I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055743	17	41246657	17	43094640	55743	70410	rs80357103	NC_000017.11:43094639:C:T
NM_007294.4(BRCA1):c.839C>G (p.Ala280Gly)	BRCA1	A280G, A233G, A152G, A153G, A212G, A253G, A168G, A192G, A209G, A213G, A112G, A232G, A279G, A169G, A191G, A210G, A238G, A239G, A254G, A277G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055731	17	41246709	17	43094692	55731	70398	rs80357199	NC_000017.11:43094691:G:C
NM_007294.4(BRCA1):c.827C>G (p.Thr276Arg)	BRCA1	T276R, T229R, T149R, T209R, T250R, T164R, T205R, T208R, T234R, T148R, T165R, T188R, T235R, T275R, T108R, T187R, T206R, T228R, T249R, T273R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037706	17	41246721	17	43094704	37706	46262	rs80357436	NC_000017.11:43094703:G:C
NM_007294.4(BRCA1):c.824G>A (p.Gly275Asp)	BRCA1	G275D, G228D, G248D, G274D, G164D, G227D, G272D, G147D, G187D, G204D, G207D, G234D, G249D, G107D, G148D, G163D, G208D, G233D, G186D, G205D	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055726	17	41246724	17	43094707	55726	70393	rs397509327	NC_000017.11:43094706:C:T
NM_007294.4(BRCA1):c.823G>A (p.Gly275Ser)	BRCA1	G275S, G228S, G205S, G272S, G107S, G148S, G164S, G186S, G207S, G208S, G234S, G249S, G187S, G204S, G233S, G274S, G147S, G163S, G227S, G248S	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055725	17	41246725	17	43094708	55725	70392	rs8176153	NC_000017.11:43094707:C:T
NM_007294.4(BRCA1):c.736T>G (p.Leu246Val)	BRCA1	L246V, L199V, L118V, L119V, L134V, L219V, L243V, L176V, L179V, L201V, L204V, L245V, L158V, L175V, L198V, L220V, L135V, L157V, L178V, L205V, L78V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041835	17	41246812	17	43094795	41835	50274	rs28897675	NC_000017.11:43094794:A:C
NM_007294.4(BRCA1):c.716A>G (p.His239Arg)	BRCA1	H239R, H192R, H128R, H150R, H194R, H213R, H112R, H191R, H238R, H71R, H168R, H169R, H171R, H172R, H197R, H111R, H127R, H151R, H198R, H212R, H236R	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055677	17	41246832	17	43094815	55677	70344	rs80357396	NC_000017.11:43094814:T:C
NM_007294.4(BRCA1):c.652T>G (p.Leu218Val)	BRCA1	L171V, L218V, L147V, L191V, L91V, L148V, L170V, L173V, L192V, L90V, L215V, L217V	not specified	Benign(Last reviewed: May 4, 2022)	criteria provided, single submitter	VCV001684697	17	41247881	17	43095864	1684697	1676725		NC_000017.11:43095863:A:C
NM_007294.4(BRCA1):c.641A>G (p.Asp214Gly)	BRCA1	D214G, D167G, D143G, D166G, D87G, D144G, D211G, D187G, D169G, D188G, D213G, D86G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 29, 2017)	reviewed by expert panel	VCV000037689	17	41247892	17	43095875	37689	46245	rs55680408	NC_000017.11:43095874:T:C
NM_007294.3(BRCA1):c.[594-2A>C;641A>G]	BRCA1	D214G, D167G, D143G, D166G, D87G, D144G, D211G, D187G, D169G, D188G, D213G, D86G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Apr 15, 2016)	reviewed by expert panel	VCV000236265	17|17	41247941	17|17	43095924	236265	46242|46245	rs80358033|rs55680408	NC_000017.11:43095923:T:G|NC_000017.11:43095874:T:C
NM_007294.4(BRCA1):c.571G>A (p.Val191Ile)	BRCA1	V191I, V144I, V120I, V121I, V146I, V64I, V164I, V165I, V188I, V190I, V143I, V63I	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037684	17	41249283	17	43097266	37684	46240	rs80357090	NC_000017.11:43097265:C:T
NM_007294.4(BRCA1):c.557C>A (p.Ser186Tyr)	BRCA1	S186Y, S139Y, S183Y, S115Y, S185Y, S59Y, S116Y, S160Y, S138Y, S141Y, S159Y, S58Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055635	17	41249297	17	43097280	55635	70302	rs55688530	NC_000017.11:43097279:G:T
NM_007294.4(BRCA1):c.536A>G (p.Tyr179Cys)	BRCA1	Y179C, Y132C, Y109C, Y178C, Y51C, Y134C, Y176C, Y131C, Y152C, Y153C, Y52C, Y108C	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037661	17	41251803	17	43099786	37661	46217	rs56187033	NC_000017.11:43099785:T:C
NM_007294.4(BRCA1):c.508C>T (p.Arg170Trp)	BRCA1	R170W, R123W, R144W, R99W, R100W, R122W, R167W, R169W, R43W, R125W, R143W, R42W	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055393	17	41251831	17	43099814	55393	70060	rs80357325	NC_000017.11:43099813:G:A
NM_007294.4(BRCA1):c.463C>G (p.Gln155Glu)	BRCA1	Q155E, Q108E, Q107E, Q128E, Q27E, Q84E, Q85E, Q110E, Q129E, Q152E, Q154E, Q28E	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055247	17	41251876	17	43099859	55247	69914	rs80357180	NC_000017.11:43099858:G:C
NM_007294.4(BRCA1):c.427G>A (p.Glu143Lys)	BRCA1	E143K, E96K, E117K, E73K, E140K, E16K, E99K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000037580	17	41256153	17	43104136	37580	46136	rs80356991	NC_000017.11:43104135:C:T
NM_007294.4(BRCA1):c.425C>A (p.Pro142His)	BRCA1	P142H, P95H, P116H, P139H, P15H, P72H, P98H	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000041823	17	41256155	17	43104138	41823	50262	rs55971303	NC_000017.11:43104137:G:T
NM_007294.4(BRCA1):c.397C>T (p.Arg133Cys)	BRCA1	R133C, R86C, R107C, R63C, R6C, R130C, R89C	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000055067	17	41256183	17	43104166	55067	69734	rs80357457	NC_000017.11:43104165:G:A
NM_007294.4(BRCA1):c.396C>A (p.Asn132Lys)	BRCA1	N132K, N85K, N129K, N5K, N62K, N88K, N106K	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000055064	17	41256184	17	43104167	55064	69731	rs80357413	NC_000017.11:43104166:G:T
NM_007294.4(BRCA1):c.370A>G (p.Ile124Val)	BRCA1	I124V, I77V, I121V, I80V, I54V, I98V	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054971	17	41256210	17	43104193	54971	69638	rs80357448	NC_000017.11:43104192:T:C
NM_007294.4(BRCA1):c.314A>G (p.Tyr105Cys)	BRCA1	Y105C, Y58C, Y35C, Y102C, Y61C, Y79C	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054780	17	41256266	17	43104249	54780	69447	rs28897673	NC_000017.11:43104248:T:C
NM_007294.4(BRCA1):c.305C>G (p.Ala102Gly)	BRCA1	A102G, A55G, A76G, A99G, A58G, A32G	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Jun 18, 2019)	reviewed by expert panel	VCV000037505	17	41256275	17	43104258	37505	46061	rs80357190	NC_000017.11:43104257:G:C
NM_007294.4(BRCA1):c.199G>T (p.Asp67Tyr)	BRCA1	D67Y, D20Y	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000054431	17	41258486	17	43106469	54431	69098	rs80357102	NC_000017.11:43106468:C:A
NM_007294.4(BRCA1):c.133A>C (p.Lys45Gln)	BRCA1	K45Q	Breast-ovarian cancer, familial, susceptibility to, 1	Benign(Last reviewed: Aug 10, 2015)	reviewed by expert panel	VCV000183950	17	41267744	17	43115727	183950	185127	rs769650474	NC_000017.11:43115726:T:G
